Effect of microsomal enzyme inducers on the biliary excretion of cardiac glycosides.
D000704:Analysis of Variance; D000818:Animals; D001646:Bile / Q000032:analysis / Q000378:metabolism*; D001711:Biotransformation; D002301:Cardiac Glycosides / Q000378:metabolism*; D004074:Digitoxin / Q000378:metabolism / Q000633:toxicity; D004077:Digoxin / Q000378:metabolism / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D004790:Enzyme Induction / Q000187:drug effects; D007928:Lethal Dose 50; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008748:Methylcholanthrene / Q000494:pharmacology; D008861:Microsomes / Q000201:enzymology*; D009206:Myocardium / Q000378:metabolism; D009929:Organ Size; D010042:Ouabain / Q000378:metabolism / Q000633:toxicity; D010243:Paralysis / Q000139:chemically induced; D010634:Phenobarbital / Q000494:pharmacology; D011285:Pregnenolone Carbonitrile / Q000494:pharmacology; D051381:Rats; D013148:Spironolactone / Q000494:pharmacology; D013997:Time Factors; D014316:Tritium; D015049:Zoxazolamine
D002301:Cardiac Glycosides; D014316:Tritium; D011285:Pregnenolone Carbonitrile; D013148:Spironolactone; D008748:Methylcholanthrene; D010042:Ouabain; D004077:Digoxin; D015049:Zoxazolamine; D004074:Digitoxin; D010634:Phenobarbital